Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fujiya

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Hepato-Gastroenterology|August 3, 1999
Diagnostic capability and rational resectional surgery for early gallbladder cancerK Ouchi, T Sugawara, H Ono, et al.
Digestive Surgery|April 27, 2000
Hepatectomy using an ultrasonically activated scalpel for hepatocellular carcinomaK Ouchi, J Mikuni, T Sugawara, et al.
Digestive Surgery|March 18, 2000
Mitotic index is the best predictive factor for survival of patients with resected hepatocellular carcinomaK Ouchi, T Sugawara, H Ono, et al.
The British Journal of Surgery|October 20, 2007
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancerT Nakajima, T Kinoshita, A Nashimoto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 5, 2016
Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)A Tsuburaya, N Sugimoto, H Imamura, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hepato-Gastroenterology|August 3, 1999
Diagnostic capability and rational resectional surgery for early gallbladder cancerK Ouchi, T Sugawara, H Ono, et al.
Digestive Surgery|April 27, 2000
Hepatectomy using an ultrasonically activated scalpel for hepatocellular carcinomaK Ouchi, J Mikuni, T Sugawara, et al.
Digestive Surgery|March 18, 2000
Mitotic index is the best predictive factor for survival of patients with resected hepatocellular carcinomaK Ouchi, T Sugawara, H Ono, et al.
The British Journal of Surgery|October 20, 2007
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancerT Nakajima, T Kinoshita, A Nashimoto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 5, 2016
Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)A Tsuburaya, N Sugimoto, H Imamura, et al.
Pageof 2